Bladder Cancer
📧 Sign up to get email alerts when something new happens for Bladder Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-09-11Clinical Trial Update: JING SI HERBAL TEA and Urinary Tract Symptoms in Bladder Cancer [NA]
A clinical trial update for JING SI HERBAL TEA investigating urinary tract symptoms in bladder cancer patients; enrollment is by invitation …
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: Fluorouracil, Leucovorin, Gemcitabine, and Cisplatin in Treating Patients With Metastatic or Unresectable Adenocarcinoma of the Urothelium or Urachal Remnant [Phase 2]
Phase 2 clinical trial evaluating a four-drug combination—fluorouracil, leucovorin, gemcitabine, and cisplatin—for metastatic or unresectabl…
-
CLINICAL_TRIALS trial_result · 2025-09-08Clinical Trial Update: Dietary Fiber During Radiotherapy - a Placebo-controlled Randomized Trial [Phase 3]
Phase 3 randomized, placebo-controlled trial evaluating dietary fiber during radiotherapy in cancer patients has completed.
-
CLINICAL_TRIALS trial_result · 2025-09-08Clinical Trial Update: Intervention of Bladder Cancer by CAR-T [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating a CAR-T cell therapy for bladder cancer (urothelial carcinoma of the bladder) is currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-05Clinical Trial Update: A Genotype-Phenotype Urothelial Cancer Registry
A genotype-phenotype urothelial cancer registry sponsored by Memorial Sloan Kettering Cancer Center; the study is active but not recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2025-09-04Clinical Trial Update: PET Imaging Using 64Cu-Tz-SarAr and hu5B1-TCO in People With Pancreatic, Colorectal, Bladder Cancer or Cancers With Elevated CA19.9 [Phase 1]
Phase 1 trial evaluating PET imaging agents 64Cu-Tz-SarAr and hu5B1-TCO in pancreatic, colorectal, and bladder cancers (including cancers wi…
-
CLINICAL_TRIALS research · 2025-09-03Clinical Trial Update: Efficacy and Safety of Two Bladder-preserving Treatment Durations With Disitamab Vedotin Plus Toripalimab Combination in Her2-expressing Muscle-invasive Bladder Cancer: A Phase II, Open-Label, Randomized Clinical Trial [Phase 2]
This Phase II, open-label, randomized trial assesses two bladder-preserving durations of Disitamab Vedotin plus Toripalimab in HER2-expressi…
-
CLINICAL_TRIALS research · 2025-09-03Clinical Trial Update: Stage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without Relatlimab [Phase 2]
Phase 2 clinical trial update on Stage II-IIIa urothelial carcinoma evaluating pre-operative nivolumab with or without relatlimab. Recruitme…
-
CLINICAL_TRIALS research · 2025-09-02Clinical Trial Update: Robot-assisted Cystectomies With Regard to Blood Loss, Pain and Transfusions.
A clinical trial investigating robot-assisted cystectomy outcomes focusing on blood loss, need for transfusions, anemia, and postoperative p…
-
CLINICAL_TRIALS research · 2025-09-02Clinical Trial Update: Gemcitabine/Cisplatin Plus Cemiplimab With or Without Fianlimab in Localized Muscle-invasive Bladder Cancer (NeoSTOP-IT) [Phase 2]
Phase 2 trial NeoSTOP-IT evaluating gemcitabine/cisplatin plus cemiplimab with or without fianlimab in localized muscle-invasive bladder can…
-
CLINICAL_TRIALS research · 2025-08-26Clinical Trial Update: A Clinical Study Evaluating the Efficacy and Safety of Disitamab Vedotin Combined With PD-1 Inhibitor and Radiotherapy as Bladder-preserving Therapy in Patients With Localized HER2-high Expressing Muscle-invasive Bladder Urothelial Carcinoma Following Maximal Transurethral Resection [Phase 2]
Phase 2 trial assessing Disitamab Vedotin combined with a PD-1 inhibitor and radiotherapy as a bladder-preserving treatment for localized HE…
-
CLINICAL_TRIALS research · 2025-08-24Clinical Trial Update: Pilot Study of a New Nerve Grafting Method During Bladder Cancer Surgery to Help Preserve Erections. [NA]
A pilot study is evaluating a new nerve grafting technique used during bladder cancer surgery to preserve erections; the trial is sponsored …
-
CLINICAL_TRIALS research · 2025-08-22Clinical Trial Update: ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Guardant Health's ORACLE trial is currently recruiting to evaluate residual cancer using a liquid biopsy across multiple cancer types.
-
CLINICAL_TRIALS trial_result · 2025-08-17Clinical Trial Update: Trilaciclib, a CDK 4/6 Inhibitor, in Patients With Advanced/Metastatic Bladder Cancer Receiving Chemotherapy Then Avelumab [Phase 2]
This is a Phase 2 trial evaluating trilaciclib in combination with chemotherapy followed by avelumab for advanced/metastatic urothelial carc…
-
CLINICAL_TRIALS trial_result · 2025-08-17Clinical Trial Update: Immunotherapy With or Without Radiation Therapy for Metastatic Urothelial Cancer [Phase 2]
A Phase 2 trial of immunotherapy with or without radiation therapy for metastatic urothelial carcinoma, including platinum-resistant disease…
-
CLINICAL_TRIALS research · 2025-08-17Clinical Trial Update: Construction of a Deep Learning-Based Precise Diagnostic Framework for Bladder Tumors Using Ultrasound: A Multicenter, Ambispective Cohort Study
A multicenter ambispective cohort study evaluating a deep learning–based ultrasound diagnostic framework for bladder tumors; the trial is cu…
-
CLINICAL_TRIALS research · 2025-08-15Clinical Trial Update: Intravesical Hyaluronic Acid (HA) for Preventing Radiation Cystitis on Bladder Cancer [NA]
A clinical trial evaluating intravesical hyaluronic acid to prevent radiation cystitis in bladder cancer; currently not yet recruiting, spon…
-
CLINICAL_TRIALS research · 2025-08-14Clinical Trial Update: Decision Making for Urinary Diversion in Patients With Bladder Cancer
Completed clinical trial update examining decision making for urinary diversion in patients with bladder cancer.
-
CLINICAL_TRIALS research · 2025-08-14Clinical Trial Update: Intravesical Treatment of Bladder Cancer at Home, Multi-modal Treatment Support [NA]
This entry describes an ongoing University of Pennsylvania clinical trial testing intravesical treatment of bladder cancer at home with mult…
-
CLINICAL_TRIALS research · 2025-08-14Clinical Trial Update: Bladder Fiducial Markers and Multiparametric-MRI (Mp-MRI) to Optimize Bladder Chemo-radiotherapy [NA]
A clinical trial at Cedars-Sinai Medical Center is evaluating the use of bladder fiducial markers and multiparametric MRI to optimize bladde…
-
CLINICAL_TRIALS research · 2025-08-13Clinical Trial Update: Application of Pericapsular Nerve Group (PENG) Block [NA]
Clinical trial update on using pericapsular nerve group (PENG) block for TURBT; the study is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2025-08-13Clinical Trial Update: Clinical Trial on the Protective Role of Vitamin B3 in Enhancing Immunotherapy for Bladder Cancer Patients [Phase 1]
A Phase 1 clinical trial is investigating whether Vitamin B3 can enhance immunotherapy in patients with bladder cancer, with the study curre…
-
CLINICAL_TRIALS research · 2025-08-12Clinical Trial Update: Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers [Phase 1]
Phase 1 clinical trial examining the biodistribution of the Ga-68 labeled imaging tracer 68Ga-FAPi-46 in patients with solid tumors and hema…
-
CLINICAL_TRIALS research · 2025-08-11Clinical Trial Update: Clinical Trail of Neoadjuvant of Tislelizumab Combined With Palbociclib in Patients With Platinum-refractory Bladder Urothelial Carcinoma [Phase 1, Phase 2]
A Phase 1/2 neoadjuvant trial evaluating tislelizumab in combination with palbociclib for platinum-refractory bladder urothelial carcinoma i…
-
CLINICAL_TRIALS trial_result · 2025-08-11Clinical Trial Update: A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid Tumours [Phase 1, Phase 2]
Cancer Research UK reported an ongoing Phase 1/2a trial of HMBD-001 in HER3-positive solid tumors; the study is currently Active Not Recruit…